Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
15 hedge funds and large institutions have $588K invested in Guardion Health Sciences, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
25% more funds holding
Funds holding: 12 → 15 (+3)
13% less capital invested
Capital invested by funds: $675K → $588K (-$87.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$138K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$128K |
| 3 |
HF
HRT Financial
New York
|
+$117K |
| 4 |
Renaissance Technologies
New York
|
+$19.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.21K |
| 2 |
Morgan Stanley
New York
|
-$1.01K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $215K | +$19.1K | +1,884 | +5% |
|
|
2
UBS Group
Zurich,
Switzerland
| $95.2K | +$138K | +13,597 | +378% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $82.3K | – | – | – |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $69.9K | +$128K | +12,609 | New |
|
|
HF
5
HRT Financial
New York
| $64K | +$117K | +11,579 | New |
|
6
BlackRock
New York
| $55.6K | – | – | – |
|
|
7
Morgan Stanley
New York
| $3.1K | -$1.01K | -100 | -15% |
|
8
Citigroup
New York
| $2.07K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $277 | -$7.21K | -712 | -93% |
|
|
CPG
10
Cornerstone Planning Group
Fairfield,
New Jersey
| $122 | – | – | – |
|
|
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $94 | – | – | – |
|
|
12
Bank of America
Charlotte,
North Carolina
| $55 | +$20 | +2 | +25% |
|
13
Osaic Holdings
Scottsdale,
Arizona
| $33 | – | – | – |
|
14
Wells Fargo
San Francisco,
California
| $6 | – | – | – |
|
|
TWC
15
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $3 | +$10 | +1 | New |
|
GHSI Hedge Fund Activity: Q3 2024 in Review
15 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q3 2024, worth a combined $588K — down 13% from $675K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GHSI positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $138K. The largest seller was Tower Research Capital (TRC), cutting an estimated $7.21K.
- 15 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q3 2024, up from 12 in Q2 2024.
- Funds reported $588K of Guardion Health Sciences, Inc. Common Stock stock for Q3 2024, down 13% quarter-over-quarter.
- 3 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q3 2024 and 0 closed out, a net change of +3 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q3 2024 was UBS Group, an estimated $138K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q3 2024 was Tower Research Capital (TRC), an estimated $7.21K sold.
Based on aggregated 13F filings for Q3 2024.